Riboflavin for migraine prevention: promising dose, delayed answer
Trials support a possible preventive role for 400 mg riboflavin, but benefit takes time and does not replace migraine diagnosis or acute care.

Riboflavin has more migraine evidence than many wellness uses, yet response is not immediate or universal and studied doses are far above nutritional needs.
Why vitamin B2 entered migraine research
Riboflavin, or vitamin B2, helps form cofactors used in cellular energy metabolism. One migraine hypothesis involves impaired mitochondrial energy handling, which made high-dose riboflavin a plausible preventive intervention. The rationale is more specific than a generic energy claim, but plausibility still required randomized trials.
Migraine prevention aims to reduce attack frequency, days, severity, or disability over time. It differs from acute treatment taken after pain begins. A preventive supplement should not be judged after one dose or used as a substitute for urgent evaluation of a first, sudden, or neurologically unusual headache.

The classic randomized trial
A three-month randomized placebo-controlled trial enrolled 55 people with migraine and tested 400 milligrams of riboflavin daily. Riboflavin reduced attack frequency and headache days more than placebo, and more participants achieved at least a 50 percent improvement. The sample was small, but the study established a credible signal for further work.
Because the dose was hundreds of times the adult nutritional requirement, the trial tested a pharmacologic strategy rather than ordinary deficiency prevention. Results should be linked to that schedule and duration. A low-dose multivitamin cannot claim the same evidence merely because it contains riboflavin.
Newer syntheses remain encouraging but imperfect
A 2025 systematic review and dose-response meta-analysis included 12 trials with 749 participants and found reductions in migraine frequency and duration, with substantial heterogeneity. A 2026 network meta-analysis of nutraceutical trials rated the 400-milligram riboflavin signal for adult attack frequency as moderate certainty.
Network comparisons rely partly on indirect evidence because not every supplement has been tested head to head. The 2026 authors also noted sparse data for several interventions and called for larger standardized trials. Riboflavin ranked well in that evidence set, but rankings are not guarantees for an individual patient.
Expect a prevention timeline, not an instant effect
Migraine preventives are usually assessed over weeks to months with a headache diary. Record attack days, severity, acute-medication use, and disability before changing several treatments at once. Bright-yellow urine is an expected effect of riboflavin excretion and does not indicate dehydration or that the product is working.
Gastrointestinal effects can occur, and adherence may be harder with large capsules or divided doses. Product quality matters because supplement content can vary. A clinician can help decide whether riboflavin fits alongside prescription prevention, acute medicines, contraception, pregnancy planning, and other health conditions.

Headache red flags outrank supplement trials
Seek urgent care for a thunderclap headache, new weakness or numbness, confusion, fever with neck stiffness, head injury, new headache during pregnancy, or a major change in pattern. New headaches after age 50 or headaches with vision loss also need timely assessment. A supplement trial should begin only after the diagnosis is reasonably clear.
Medication-overuse headache, sleep disorders, dehydration, skipped meals, hormonal patterns, caffeine changes, and other triggers can influence attack frequency. Riboflavin is one possible preventive tool, not a complete migraine plan and not proof that every headache comes from mitochondrial dysfunction.
How to compare products honestly
Look for the exact riboflavin amount per daily serving, other active ingredients, independent quality testing, and a feasible trial duration. Combination migraine products make attribution difficult, especially when they also contain magnesium, feverfew, butterbur, or CoQ10 with different safety profiles.
Discuss a defined stop rule if there is no meaningful improvement after an adequate trial. The evidence supports cautious optimism for high-dose riboflavin prevention in diagnosed migraine. It does not support instant relief, guaranteed response, or casual use of a high-potency B complex for any recurring head pain.
Riboflavin has few known serious interactions, but a high-dose migraine regimen should still appear on the medication list. Combination products can obscure the amount and expose users to ingredients with liver, pregnancy, allergy, or anticoagulant concerns. Insurance coverage and cost may also influence whether a simple single-ingredient product is preferable. The goal is a sustainable preventive plan with measurable benefit, not the most elaborate migraine formula on the shelf.
Sources & further reading
This article is educational and does not diagnose, treat, or replace individual medical advice. Ask a qualified clinician or pharmacist about symptoms, medical conditions, and possible interactions before using supplements.